In cancer patients, VEGF stimulates dysregulated neoangiogenesis, protects tumor cells from apoptosis, and increases the resistance to conventional oncological treatments; thus, VEGF has a pivotal role in tumor growth, proliferation and spread [7,8]. This evidence concerns the gene VEGFA and cancer.